...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of the FecalSwab for Stool Specimen Storage and Molecular Detection of Enteropathogens on the BD Max System
【24h】

Evaluation of the FecalSwab for Stool Specimen Storage and Molecular Detection of Enteropathogens on the BD Max System

机译:BD MAX系统对粪便标本储存的粪便样本储存和分子检测的评价

获取原文
           

摘要

The FecalSwab system (Copan Italia, Brescia, Italy) is a convenient alternative to bulk stool for the diagnosis of enteric pathogens. Although the U.S. Food and Drug Administration (FDA) approved for transport and culture of enteric bacterial pathogens, the FecalSwab has not been well assessed for its suitability with molecular platforms. In this study, we evaluated the FecalSwab as a specimen type for the BD Max system using the viral and bacterial enteric panels (BD Diagnostics, Baltimore, MD, USA). ABSTRACT The FecalSwab system (Copan Italia, Brescia, Italy) is a convenient alternative to bulk stool for the diagnosis of enteric pathogens. Although the U.S. Food and Drug Administration (FDA) approved for transport and culture of enteric bacterial pathogens, the FecalSwab has not been well assessed for its suitability with molecular platforms. In this study, we evaluated the FecalSwab as a specimen type for the BD Max system using the viral and bacterial enteric panels (BD Diagnostics, Baltimore, MD, USA). A total of 186 unpreserved stool specimens were collected and used to prepare matched bulk stool and FecalSwab samples. Performance was equivalent ( P ?&?0.48) to bulk stool for all targets when 50?μl of FecalSwab specimen was loaded onto the BD Max assays. As stool specimens are often collected off-site from the clinical microbiology laboratory and require transport, we assessed the stability of stool specimens stored for up to 14?days at 4°C, 22°C, or 35°C to account for varying transportation conditions. Molecular detection for the majority of viral targets (excluding astrovirus) was unaffected (change in cycle threshold [Δ C _(T) ]?≤?1) by sample storage temperature over the 2-week period; however, detection of enteric bacteria was variable if specimens were not refrigerated (22°C or 35°C). By demonstrating equivalent performance to matched bulk stool and maintaining molecular detection sensitivity when stored at 4°C, we suggest that the FecalSwab is a suitable specimen type for enteropathogen diagnostics on the BD Max system.
机译:Fecalswab系统(Copan Italia,Brescia,意大利)是一种方便的替代方案,用于诊断肠道病原体。虽然美国食品和药物管理局(FDA)批准用于肠道细菌病原体的运输和培养,但FecalsWab尚未得到很好的评估其与分子平台的适用性。在这项研究中,我们使用病毒和细菌肠面板(BD诊断,Baltimore,MD,USA)评估了FecalsWab作为BD Max系统的标本类型。摘要Fecalswab系统(Copan Italia,Brescia,意大利)是一种方便的替代方案,用于诊断肠溶病原体。虽然美国食品和药物管理局(FDA)批准用于肠道细菌病原体的运输和培养,但FecalsWab尚未得到很好的评估其与分子平台的适用性。在这项研究中,我们使用病毒和细菌肠面板(BD诊断,Baltimore,MD,USA)评估了FecalsWab作为BD Max系统的标本类型。收集了总共186种未验证的粪便标本,并用于制备匹配的散装粪便和粪便驱动样本。当将50℃的葡萄糖样品加载到BD MAX测定上时,性能是等效的(p?&Δ0.48),适用于当50°μl的鲸袋样品上时靶向所有靶标的粪便。随着粪便标本通常从临床微生物实验室脱田,我们需要运输,我们评估了在4°C,22°C,或35°C时储存最多14天的粪便样本的稳定性,以考虑不同的运输使适应。大多数病毒靶标(不包括Astrovirus)的分子检测不受影响(通过样品储存温度在2周期间通过样品储存温度改变循环阈值[ΔC_(t)]≤≤1);然而,如果样品没有冷藏(22℃或35℃),则肠道细菌的检测是可变的。通过对匹配的散装粪便进行等效性能并保持分子检测灵敏度,我们建议FecalsWab是BD Max系统上的肠病诊断的合适标本类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号